Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ARGX · against 1,372 other Healthcare companies
Ranked #205 of 1,373 · scores higher than 85% of peers · safety percentile 85
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)137 peers with a safety percentile of 80–89, including ARGX · Click a bar to see the companies
Mainly thanks to its debt / equity and current ratio, which are stronger than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | ARGX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 1,280 reported | 0.01× | 0.24× | 93% | 33% | |
| BetaLower is better · 1,320 reported | -0.04 | 0.53 | 94% | 33% | |
| Current ratioHigher is better · 1,338 reported | Not reported | 2.62× | — | — | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 186M USD | 100 | 52 | |
| 4 | 1.5B USD | 100 | 44 | |
| 5 | 1.2B USD | 100 | 40 | |
| 201 | 2.8B SGD (≈$2.2B) | 85 | 67 | |
| 202 | 5.1B USD |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 35 |
| 203 | 142M USD | 85 | 45 |
| 204 | 5.8B CNY (≈$807M) | 85 | 67 |
| 205 | 56.7B USD | 85 | 79 |
| 206 | 1.3B USD | 85 | 27 |
| 207 | 1.1B USD | 85 | 50 |
| 208 | 30.4B JPY (≈$206M) | 85 | 57 |
| 209 | 987M CHF (≈$1.1B) | 85 | 42 |